Onabet SD Solution is a topical pharmaceutical formulation containing Sertaconazole nitrate (2% w/v) and Mometasone furoate (0.1% w/v), designed for the treatment of inflammatory and fungal skin conditions. Sertaconazole is a broad-spectrum antifungal agent belonging to the imidazole class, exhibiting potent activity against dermatophytes, yeasts, and molds by inhibiting ergosterol synthesis, thereby disrupting fungal cell membrane integrity. Mometasone furoate is a potent corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties, effectively reducing inflammation, redness, and itching associated with various dermatoses. The combination of Sertaconazole and Mometasone provides a synergistic effect, addressing both fungal infection and the accompanying inflammatory response. Onabet SD Solution is indicated for the management of superficial mycoses such as tinea corporis, tinea cruris, and candidiasis, especially when inflammation and pruritus are prominent. The solution formulation allows for easy application and rapid absorption, enhancing patient compliance. Caution is advised in patients with hypersensitivity to any component, and prolonged use should be avoided to minimize potential corticosteroid-related adverse effects. Onabet SD Solution should be used under medical supervision, adhering to prescribed dosage and duration to ensure optimal therapeutic outcomes.